Michael Asensio

Director R&D at GigaGen, Inc (A subsidiary of Grifols, S.A.)

Speaker

Michael Asensio is the Director of Research and Development at GigaGen, Inc. (a subsidiary of Grifols). After earning his M.S. from the UC Berkeley/UCSF joint Bioengineering program, he joined GigaGen and helped build the microfluidic and molecular biology platform technologies to produce the first recombinant polyclonal antibodies. His current role focuses on capturing and engineering antibody repertoires to create novel therapeutics for a variety of diseases.